Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial.

Antimicrob Agents Chemother · 2022 · PMC9112969 · PMID 35404075

Europe PMC DOI

hedged sentence

0.0562

closest p · 1.1× alpha

0.0562

boldest claim

The sentences

did not reach statistical significanceP = 0.0562so close (0.05 < p ≤ 0.1)

In another randomized, placebo-controlled study in adults with MDR-TB, median time to sputum culture conversion was lower in the delamanid plus OBR arm than in the placebo plus OBR arm, but the difference did not reach statistical significance ( P = 0.0562 for the comparison) ( 15 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.